Trivascular Technologies, Inc.
SEC CIK 1432732 · TRIV · last insider filing 2016-02-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Roeder Douglas A | Director | filed 2014 - 2016 |
| Chavez Christopher G. | Director · President, CEO and Chairman | filed 2014 - 2016 |
| Thomas Robert | Director | filed 2014 - 2016 |
| Scopa James Paul | Director | filed 2014 - 2016 |
| Moore Daniel Jeffrey | Director | filed 2014 - 2016 |
| Drant Ryan D | Director | filed 2014 - 2015 |
| Nunn Jason Raleigh | Director | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kramer Michael R | Chief Financial Officer | filed 2014 - 2016 |
| Elting Kimberley A. | VP, Gen. Counsel and Secretary | filed 2014 - 2016 |
| Chobotov Michael V. | Chief Technology Officer | filed 2014 - 2016 |
| O'Quinn Shari L | VP Clinical/Regulatory Affairs | filed 2014 - 2016 |
| Jayaraman Vivek K | VP Global Sales and Marketing | filed 2014 - 2016 |
| Whirley Robert G | VP Research and Development | filed 2014 - 2015 |
| Molinari Louis J. | VP Manufacturing Operations | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.